IMM 20.3% 35.5¢ immutep limited

ann: positive interim data from can-003 trial, page-7

  1. 15,518 Posts.
    lightbulb Created with Sketch. 43
    The "real" buyers are out there and will be paying serious attention to this and the final CAN003 results.

    They are the likes of GSK, Merck, J&J etc.

    Fat cheque books, looking for an opportunity to broaden their product offering with a marketing deal or JV.

    This good interim result will put PRR on their radar.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.